These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 38578470

  • 1. Are children with IgA nephropathy different from adult patients?
    Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, Zhong F, Sun S, Zhang D, Xia Z, Feng C, Huang W, Li X, Chen C, Hao Z, Wang M, Qin L, Chen M, Li Y, Ding J, Bao Y, Liu X, Deng F, Cheng X, Zhang L, Zhang X, Yang H, Peng X, Sun Q, Deng L, Jiang X, Xie M, Gao Y, Yu L, Liu L, Gao C, Mao J, Zheng W, Dang X, Xia H, Wang Y, Zhong X, Ding J, Lv J, Zhang H.
    Pediatr Nephrol; 2024 Aug; 39(8):2403-2412. PubMed ID: 38578470
    [Abstract] [Full Text] [Related]

  • 2. Clinical and histological differences between adults and children in new onset IgA nephropathy.
    Cambier A, Rabant M, El Karoui K, Peuchmaur M, Servais A, Hertig A, Deschenes G, Salomon R, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925
    [Abstract] [Full Text] [Related]

  • 3. Crescentic IgA nephropathy in children.
    Shima Y, Nakanishi K, Hama T, Mukaiyama H, Sato M, Tanaka Y, Tanaka R, Kaito H, Nozu K, Sako M, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2020 Jun; 35(6):1005-1014. PubMed ID: 31993782
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of corticosteroid therapy for IgA nephropathy patients stratified by kidney function and proteinuria.
    Nagasawa Y, Yamamoto R, Shinzawa M, Shoji T, Hasuike Y, Nagatoya K, Yamauchi A, Hayashi T, Kuragano T, Moriyama T, Isaka Y.
    Clin Exp Nephrol; 2020 Oct; 24(10):927-934. PubMed ID: 32642919
    [Abstract] [Full Text] [Related]

  • 5. IgA Nephropathy in Children: A Multicenter Study in Poland.
    Mizerska-Wasiak M, Turczyn A, Such A, Cichoń-Kawa K, Małdyk J, Miklaszewska M, Pietrzyk J, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Szczepańska M, Bieniaś B, Zajączkowska M, Pukajło-Marczyk A, Zwolińska D, Siniewicz-Luzeńczyk K, Tkaczyk M, Gadomska-Prokop K, Grenda R, Demkow U, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2016 Oct; 952():75-84. PubMed ID: 27573641
    [Abstract] [Full Text] [Related]

  • 6. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function.
    Ogura S, Moriyama T, Miyabe Y, Karasawa K, Nitta K.
    Clin Exp Nephrol; 2021 Oct 14; 25(10):1103-1110. PubMed ID: 34101029
    [Abstract] [Full Text] [Related]

  • 8. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y, Moriyama T, Uchida K, Tsuchiya K, Nitta K.
    Clin Exp Nephrol; 2017 Aug 14; 21(4):617-623. PubMed ID: 27549901
    [Abstract] [Full Text] [Related]

  • 9. Estimated glomerular filtration rate and daily amount of urinary protein predict the clinical remission rate of tonsillectomy plus steroid pulse therapy for IgA nephropathy.
    Suzuki K, Miura N, Imai H.
    Clin Exp Nephrol; 2014 Aug 14; 18(4):606-12. PubMed ID: 24052158
    [Abstract] [Full Text] [Related]

  • 10. Comparison of clinicopathological features between children and adults with IgA nephropathy.
    Wang T, Ye F, Meng H, Zhang L, Jin X.
    Pediatr Nephrol; 2012 Aug 14; 27(8):1293-300. PubMed ID: 22562475
    [Abstract] [Full Text] [Related]

  • 11. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y, Liu JC, Xiao HJ, Huang JP, Yang JY.
    Zhonghua Er Ke Za Zhi; 2004 Jun 14; 42(6):412-6. PubMed ID: 15265422
    [Abstract] [Full Text] [Related]

  • 12. Dyslipidemia may be a risk factor for progression in children with IgA nephropathy.
    Zhuang H, Lin Z, Zeng S, Jiang M, Chen L, Jiang X, Xu Y.
    Pediatr Nephrol; 2022 Dec 14; 37(12):3147-3156. PubMed ID: 35347403
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul 14; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 14. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
    Shima Y, Nakanishi K, Sato M, Hama T, Mukaiyama H, Togawa H, Tanaka R, Nozu K, Sako M, Iijima K, Suzuki H, Yoshikawa N.
    Pediatr Nephrol; 2017 Mar 14; 32(3):457-465. PubMed ID: 27714465
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive therapy for IgA nephropathy in children.
    Alladin A, Hahn D, Hodson EM, Ravani P, Pfister K, Quinn RR, Samuel SM.
    Cochrane Database Syst Rev; 2024 Jun 12; 6(6):CD015060. PubMed ID: 38864363
    [Abstract] [Full Text] [Related]

  • 16. Utility of remission criteria for the renal prognosis of IgA nephropathy.
    Matsuzaki K, Suzuki H, Kawamura T, Tomino Y, Suzuki Y.
    Clin Exp Nephrol; 2021 Sep 12; 25(9):988-995. PubMed ID: 33974158
    [Abstract] [Full Text] [Related]

  • 17. Steroid therapy in children with IgA nephropathy.
    Cambier A, Boyer O, Deschenes G, Gleeson J, Couderc A, Hogan J, Robert T.
    Pediatr Nephrol; 2020 Mar 12; 35(3):359-366. PubMed ID: 30778826
    [Abstract] [Full Text] [Related]

  • 18. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 19. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
    Li XW, Cheng SQ, Liang SS, Le WB, Zeng CH, Wang JQ, Liu ZH.
    Clin Nephrol; 2016 May 30; 85(5):273-81. PubMed ID: 26951969
    [Abstract] [Full Text] [Related]

  • 20. Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study.
    Wang Z, Zhou X, Shi S, Liu L, Lv J, Zhang H.
    Am J Nephrol; 2024 May 30; 55(5):529-538. PubMed ID: 39074466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.